Robin Mansukhani - CEO of Deciduous Therapeutics - Immunotherapy

In this episode of the Life Science Success Podcast my guest is Robin Mansukhani.  Robin is the CEO of Deciduous Therapeutics, a venture backed startup developing novel immunotherapies to treat age-related diseases. Additionally, he co-founded BlueStamp Engineering, an intensive, project-based engineering program for high school students in NYC, San Francisco, and Palo Alto.

Introduction

02:00 Tell listeners about yourself

03:33 Whenever you were in venture capital, did it help you at all in terms of looking for companies like Des Deciduous whenever you were examining companies?

04:41 Because you have that experience, does it help you as well to find funding for the companies you work with?

09:00 What made you want to come away from venture capital into, more of the medical device and also, now Phar pharmaceutical?

10:20 What led to the company's creation and to your being there? 

11:00 The name Des Deciduous you mentioned, what it is, but where did it come from?

13:55 What do you expect the outcome will be and then, where are you guys at currently?

16:00 And then in terms of blue Stamp Engineering whenever I read about this I was very interested to hear, more about, what made you start it and then what specifically is it doing as well.

22:16 And then the things that they primarily focus on though would be anything that has to do with engineering as a whole? Or is there, are there specific focus areas that Blue Stamp focuses then on?

26:14 There are three questions that I like to ask every guest.

          -What Inspires you?

27:55 -What concerns you? 

30:08 -What excites you?

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.